Vimarsana
Biggest News Aggregation in the World

Page 13 - Beate Kampmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beate Kampmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beate Kampmann Today - Breaking & Trending Today

British regulator 1st to OK updated COVID shot targeting omicron - Vimarsana News

British regulator 1st to OK updated COVID shot targeting omicron

LONDON (AP) — British drug regulators have become the first in the world to authorize an updated version of Moderna's coronavirus vaccine that includes protection against the omicron variant, which t...

Source: theday.com
British regulator 1st to OK Moderna's updated booster that targets Omicron - Vimarsana News

British regulator 1st to OK Moderna's updated booster that targets Omicron

The U.K. has authorized Moderna's new COVID-19 vaccine that aims to protect against the original virus and the Omicron variant.

Source: aol.com
UK 1st to OK Moderna's new COVID booster - Vimarsana News

UK 1st to OK Moderna's new COVID booster

LONDON — British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that includes protection against the omicron variant, which the government said would be offered to people aged 50 and...

UK regulator OKs Moderna COVID booster that targets Omicron - Vimarsana News

UK regulator OKs Moderna COVID booster that targets Omicron

The U.K. has authorized Moderna's new COVID-19 vaccine that aims to protect against the original virus and the Omicron variant.

Expert comment - UK approves dual-strain COVID-19 vaccine - Vimarsana News

Expert comment - UK approves dual-strain COVID-19 vaccine

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved a booster vaccine made by Moderna which targets two COVID-19 variants, known as a bivalent vaccine. Following clinical trial data that showed it triggers a strong immune response against both strains, the vaccine was found to meet the UK regulator's standards for safety, quality and effectiveness. Vaccine expert, Professor Beate Kampmann reacts to this announcement.